Rensselaer Polytechnic Institute Awarded $3.3 Million Grant to Improve mRNA Purification Technology
Research aims to address a critical bottleneck in the production of mRNA therapeutics.
Research aims to address a critical bottleneck in the production of mRNA therapeutics.
Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.
TROY, N.Y. — Researchers at Rensselaer Polytechnic Institute have developed a way to 3D print living skin, complete with blood vessels. The advancement, published online today in Tissue Engineering Part A, is a significant step toward creating grafts that are more like the skin our bodies produce naturally.
Anthony Bishop, Chris Newhard, and Divya Shastry have been awarded NSF Graduate Research Fellowships, while five other students have been recognized with honorable mention.
Two chemical engineering professors are contributing to the development of a method for rapidly manufacturing biologic drugs.
Listen to audio podcast on Pankaj Karande's research.
Researchers at Rensselaer Polytechnic Institute Are Developing New Technology for Pushing Drugs Through the Blood-Brain Barrier, Directly Targeting Brain Tumors